UPDATE: Goldman Sachs Downgrades Diebold to Sell on Relative Valuation, Growth Risk

Loading...
Loading...
Goldman Sachs downgraded Diebold
DBD
from Neutral to Sell and lowered the price target from $29.00 to $27.00. Goldman Sachs commented, "On a sector relative basis, we downgrade DBD to Sell from Neutral as we are now more cautious on (1) the company's core ATM demand backdrop as banks focus on controlling expenses in a tough environment; (2) potential share losses in the US regional and Brazil ATM market to NCR where its order growth has shown relative strength; and (3) potential pricing risk from a shift in orders to larger banks." Diebold closed at $30.77 on Tuesday.
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesIntraday UpdateAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...